Intrinsic Properties of the Lymph Node Render It Immunologically Susceptible to Metastasis
Open Access
- 24 April 2025
- journal article
- pancreatic cancer
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (9) , 1949-1968
Abstract
Lymph nodes (LN) are the staging grounds for antitumor immunity; therefore, their high susceptibility to metastatic colonization is a paradox. Previous studies have suggested that extrinsic tumor-derived factors precondition the draining LN to enable tumor cell survival by promoting a state of immune suppression. In this study, we investigate whether properties of the LN itself may impede its ability to clear metastasizing tumor cells. Using multiple immunocompetent transplant models, we show that LNs possess intrinsic features, independent of preconditioning, which make them an advantageous site for tumor cells to evade T-cell control. Tumor growth in the LN is facilitated by regulatory T cells, which locally suppress the cytolytic capacity of tumor-specific CD8+ T cells by restricting IL2. These findings identify an intrinsic mechanism that contributes to the high rate of LN metastasis in solid tumors. Significance: As an immune organ, the LN’s paradoxical susceptibility to metastasis has been attributed to immunosuppressive conditioning by tumor-secreted factors. We identify regulatory T cell restriction of IL2 from CD8+ T cells as an intrinsic property of LNs that renders them susceptible to metastatic colonization. See related commentary Menzel and Padera, p.1780Keywords
All Related Versions
Funding Information
- National Cancer Institute (CA252225, CA276512)
- National Cancer Institute (CA281080)
- National Natural Science Foundation of China (81874168, 82173103)
This publication has 94 references indexed in Scilit:
- Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable PrognosisThe American Journal of Pathology, 2001
- Impact of Negative Selection on the T Cell Repertoire Reactive to a Self-PeptideImmunity, 2000
- High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993Journal of Clinical Oncology, 1999
- Yersinia pestis--etiologic agent of plague.1997
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.Journal of Clinical Oncology, 1995
- Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.1994
- HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseNature, 1993
- The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency.Proceedings of the National Academy of Sciences, 1992
- Lymphoid organs function as major reservoirs for human immunodeficiency virus.Proceedings of the National Academy of Sciences, 1991
- THE MULTI-SUBUNIT INTERLEUKIN-2 RECEPTORAnnual Review of Biochemistry, 1989